Clariant offers Mevopur color range for pharma packaging

The Mevopur colorants block UV, thereby helping to protect UV sensitive pharmaceutical products.

The pre-evaluated Mevopur colourants help reduce customers’ development times and costs, and minimize risk of change during the product life-cycle.

Masterbatches and compounds utilizing the Mevopur colorants will address the industry concern regarding drug adulteration caused by leaching of substances from the plastics packaging, the company said.

Clariant Global Segment Medical & Pharmaceutical head Steve Duckworth said within the pharmaceutical packaging sector there has been increased awareness of, and much discussion of extractables and leachables from plastics and how changes in the materials may often result in unintended contamination of the drug.

"By offering a pre-evaluated range of colorants, we give our customers the confidence and ability to explore exciting new color options for their packaging, knowing that the risks and the costs of a failure in late stage development or product-life cycle are reduced," Duckworth added.

The colorants are manufactured at the company’s three ISO 13485:2003 registered dedicated medical and pharmaceutical centers of competence based in the USA, Europe and Asia.